Robert Whitfield MD emphasizes the need to identify and address chronic inflammation before interventions (e.g., surgery) by using a comprehensive program. He describes evaluating genetics; environmental toxicant burden (phthalates, MEPs, BPAs, 'BIFF'); heavy metals; mycotoxins; gut microbiome and dysbiosis; food sensitivities; and hormone balance to create a proactive, front-end plan.
Exceptionally important in this patient population who have high amounts of chronic inflammation. Because imagine I operate on you and you have chronic inflammation. If we don't do work to help address that on the front end through the program. So we look at your genetics, we do a tox test to look at your environmental tox burden. Phthalates, MEPs, BPAs, BIFF. We look at heavy metals, we look at mycotoxins. We're really trying to prepare you for and look at everything, including gut microbiome, dysbiosis, food sensitivities, hormone balance, so that we get a broad enough picture so that we can get as proactive as possible up front.
